Vital Transformation is a small, unique consultancy focused on addressing the challenges of today’s modern healthcare system. We partner with your organisation to help you find answers to hard to solve problems.
Contact us to learn how Vital Transformation can help your organisation.
LATEST RESEARCH
LATEST COMMUNICATIONS
Our Communication Services
With the continuing pressure placed upon the US biopharma sector from Washington DC, how is the California biopharma ecosystem, arguably the leading hub for innovative biotech worldwide, responding? In this Vital Health Podcast, we speak with Joseph Panetta to discuss this issue. Joe is the President & CEO of Biocom California, an organization representing over 1,800 members working in California's life sciences sector to break down barriers to doing business and advocate for innovation. As the head of Biocom California since 1999, Joe is regarded as a thought leader in biotech and life sciences globally.
Find all our communication projects on Better Science, Better Health
MORE RESEARCH
Medicines Adaptive Pathways to Patients (MAPPs): A Story of International Collaboration Leading to Implementation
21st October, 2015
After nearly a decade of discussion, analysis, and development, the Medicines Adaptive Pathways to Patients (MAPPs) initiative is
beginning to see acceptance from regulators, industry, patients, and payers, with the first live pilot project initiated under the
guidance of the European Medicines Agency in 2014.
Report: The challenges and changes needed to reengineer medicines development in the UK
9th March, 2015
A new report from the ABPI and Vermilion Life Sciences examines the challenges and changes needed for the UK to lead reengineering medicines development, and proposes a new methodology to achieve this.
TEMPEST mHealth : mHealth in 28 EU Member States
3rd November, 2014
By Wendy L. Currie and Jonathan J.M. Seddon
One of the biggest health care challenges in the coming years is how technology can be used to improve health service delivery. With the steadily increasing average life expectancy across all of Europe expected to be over 80 by 2025 and 82.5 by 2050, new and improved processes need to be delivered to meet future health requirements.
VITAL HEALTH PODCASTS
Our podcast series is also available via your favourite channels!
 |
 |
|---|---|
 |
 |
NEWSLETTER
Register now to receive all the latest updates from Vital Transformation including our research, podcasts and more...
VT on X
EU biopharma company startups declined 50% in 2018, well before the COVID pandemic #gplhttps://t.co/issED0DVJV@amgen @abbvie @abbvieuk @IAmBiotech @DuaneSchulthess @BSBHbyVT @VitalTransform pic.twitter.com/fORbCktE8z
— VitalTransformation (@VitalTransform) April 23, 2024
New study "The EU General Pharmaceutical Legislation & Clawbacks: Calculated impacts – both designed and unintended." https://t.co/issED0DnUn@amgen @AbbVie @IAmBiotech @DuaneSchulthess @BSBHbyVT @VitalTransform @abbvieuk
— VitalTransformation (@VitalTransform) April 18, 2024
Our clients include many of the world’s leading health care organisations.
